ID: ALA3885427

Max Phase: Preclinical

Molecular Formula: C20H17F3N4O3S

Molecular Weight: 450.44

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=c1nc(N2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)sc2ccc(C(F)(F)F)cc12

Standard InChI:  InChI=1S/C20H17F3N4O3S/c21-20(22,23)14-3-6-17-16(11-14)18(28)24-19(31-17)26-9-7-25(8-10-26)12-13-1-4-15(5-2-13)27(29)30/h1-6,11H,7-10,12H2

Standard InChI Key:  UDJRIIAWIMGTQD-UHFFFAOYSA-N

Associated Targets(non-human)

DNA gyrase subunit A/DNA gyrase subunit B 505 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mycobacterium tuberculosis 203094 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 450.44Molecular Weight (Monoisotopic): 450.0973AlogP: 3.91#Rotatable Bonds: 4
Polar Surface Area: 79.58Molecular Species: NEUTRALHBA: 7HBD: 0
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 5.56CX LogP: 4.14CX LogD: 4.13
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.44Np Likeness Score: -2.05

References

1. Chaudhari K, Surana S, Jain P, Patel HM..  (2016)  Mycobacterium Tuberculosis (MTB) GyrB inhibitors: An attractive approach for developing novel drugs against TB.,  124  [PMID:27569197] [10.1016/j.ejmech.2016.08.034]

Source